Mindray Medical International Limited (
) will begin trading ex-dividend on March 06, 2013. A cash dividend
payment of $0.5 per share is scheduled to be paid on April 12,
2013. Shareholders who purchased MR stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
25% increase over the prior year.
The previous trading day's last sale of MR was $37.58,
representing a -3.12% decrease from the 52 week high of $38.79 and
a 43.6% increase over the 52 week low of $26.17.
MR is a part of the Health Care sector, which includes companies
such as 3M Company (
) and Baxter International Inc. (
). MR's current earnings per share, an indicator of a company's
profitability, is $1.52. Zacks Investment Research reports MR's
forecasted earnings growth in 2013 as 25.25%, compared to an
industry average of 5.2%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to MR through an Exchange
Traded Fund [ETF]?
The following ETF(s) have MR as a top-10 holding:
- EGShares Health Care GEMS ETF (
The top-performing ETF of this group is HGEM with an increase of
21.55% over the last 100 days. It also has the highest percent
weighting of MR at 4.82%.